SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 9, 2026

AXSM

Axsome Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $9.2M total
Actionable Insight • Neutral

The CEO/CFO sales are likely liquidity-driven following option exercises, not a bearish signal on fundamentals given the modest proportion of market cap. However, the cluster of three insiders selling within a week, including the CEO and CFO, adds mild caution. Monitor for any pipeline news (e.g., AXS-07, AXS-12, solriamfetol updates) that could explain the timing.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$246.34
T+0 close · Jun 9, 2026 · via day close
Latest settled
−15.42%
T+60 · $208.35
Vs SPY
−22.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 10 $246.34entry
  2. T+1 · 5mo ago +3.02%α +1.32% · $253.77
  3. T+5 · 5mo ago +2.26%α −1.17% · $251.91
  4. T+20 · 4mo ago +1.06%α −2.56% · $248.95
  5. T+60 · 2mo ago −15.42%α −22.00% · $208.35
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Herriot and CFO Pizzie exercised stock options and immediately sold the resulting shares in open-market transactions on June 9, 2026, generating ~$19.9M in total proceeds. Director Coleman also sold $1.24M on June 2. The cluster is entirely sell-side with $21.1M in open-market sales, representing ~0.17% of AXSM's $12.1B market cap, a modest but notable amount. The CEO/CFO sales follow option exercises and are likely tax/planning driven, but the timing ahead of potential catalysts (e.g., pipeline updates) warrants monitoring.

Key Financial Metrics

Direction
selling
Total Value
$21.1M
Insiders
3

Key Facts

  • CEO Herriot sold 49,670 shares at ~$241.01 for ~$12.0M on June 9, 2026
  • CFO Pizzie sold 33,000 shares at ~$240.09 for ~$7.9M on June 9, 2026
  • Both CEO and CFO exercised options at $0-$4.95 cost basis before selling, no net cash outlay for the shares
  • Director Coleman sold 5,500 shares at $223.39 for ~$1.24M on June 2, 2026
  • Total open-market sales: ~$21.1M, or ~0.17% of AXSM's $12.1B market cap
  • Two directors received non-cash grants of 1,721 shares each on June 5, 2026, no economic signal
  • AXSM has 93% analyst bullish consensus (25 Buy/Strong Buy, 2 Hold)

Financial Impact

Total insider sales of ~$21.1M represent ~0.17% of market cap, modest but notable for a biotech with significant pipeline value

insider ownershipdilution

Risk Factors

  • CEO/CFO selling after option exercises could signal reduced conviction ahead of pipeline milestones
  • Director Coleman's sale at a lower price ($223.39) vs. CEO/CFO ($240-241) suggests no coordinated bearish view
  • Biotech sector volatility could amplify any negative read-through from insider sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AXSM-1781039864729

Track record

26 reports on AXSM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 No price data
  2. Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
  3. Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
  4. Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
  5. Aug 10, 202614w ago 8-K Neutral 6/10 No price data
  6. Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
  7. Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
  8. Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
  9. Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
  10. Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (11h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026